VistaGen Therapeutics Inc. (NASDAQ: VTGN)
$2.7650
+0.1850 ( +7.17% ) 159.9K
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Market Data
Open
$2.7650
Previous close
$2.5800
Volume
159.9K
Market cap
$77.29M
Day range
$2.5700 - $2.7850
52 week range
$2.4800 - $5.8600
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 76 | Jan 09, 2024 |
| 8-k | 8K-related | 15 | Jan 03, 2024 |
| 4 | Insider transactions | 2 | Jan 03, 2024 |
| 4 | Insider transactions | 2 | Jan 03, 2024 |
| 10-q | Quarterly Reports | 48 | Nov 09, 2023 |
| 8-k | 8K-related | 15 | Nov 09, 2023 |
| 8-k/a | 8K-related | 13 | Nov 07, 2023 |
| 8-k | 8K-related | 13 | Nov 06, 2023 |